Trkulja, V. (2021). Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology, 77. (6), 935-937. doi: 10.1007/s00228-020-03085-7
Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology, vol. 77, no. 6, 2021, pp. 935-937. https://doi.org/10.1007/s00228-020-03085-7
Trkulja, Vladimir. "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing." European Journal of Clinical Pharmacology 77, no. 6 (2021): 935-937. https://doi.org/10.1007/s00228-020-03085-7
Trkulja, V. (2021) 'Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing', European Journal of Clinical Pharmacology, 77(6), pp. 935-937. doi: 10.1007/s00228-020-03085-7
Trkulja V. Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European Journal of Clinical Pharmacology [Internet]. 2021 January 06 [cited 2024 August 20];77(6):935-937. doi: 10.1007/s00228-020-03085-7
V. Trkulja, "Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing", European Journal of Clinical Pharmacology, vol. 77, no. 6, pp. 935-937, January 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:524286. [Accessed: 20 August 2024]